AU Stock MarketDetailed Quotes

TRP Tissue Repair Ltd

Watchlist
  • 0.265
  • -0.010-3.64%
20min DelayMarket Closed Nov 8 15:15 AET
16.02MMarket Cap-3897P/E (Static)

Tissue Repair Ltd Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
Operating cash flow (direct method)
Cash income from operating activities
-70.19%164.8K
285.63%552.9K
143.38K
Revenue from customers
4,770.01%164.8K
--3.38K
----
Other cash income from operating activities
----
283.27%549.51K
--143.38K
Cash paid
-11.51%-5.83M
-26.88%-5.23M
-4.12M
Payments to suppliers for goods and services
-11.51%-5.83M
-26.88%-5.23M
---4.12M
Direct interest received
70.17%712.68K
4,048.96%418.8K
--10.09K
Operating cash flow
-16.35%-4.95M
-7.29%-4.26M
---3.97M
Investing cash flow
Cash flow from continuing investing activities
-49.51%-3.36K
42.81%-2.24K
-3.92K
Net PPE purchase and sale
-49.51%-3.36K
42.81%-2.24K
---3.92K
Cash from discontinued investing activities
Investing cash flow
-49.51%-3.36K
42.81%-2.24K
---3.92K
Financing cash flow
Cash flow from continuing financing activities
21.36M
Net common stock issuance
----
----
--21.36M
Cash from discontinued financing activities
Financing cash flow
----
----
--21.36M
Net cash flow
Beginning cash position
-15.94%21.4M
227.87%25.46M
--7.76M
Current changes in cash
-16.37%-4.95M
-124.48%-4.26M
--17.39M
Effect of exchange rate changes
-100.42%-843
-33.80%198.87K
--300.43K
End cash Position
-23.16%16.44M
-15.94%21.4M
--25.46M
Free cash from
-16.37%-4.95M
-7.24%-4.26M
---3.97M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2024(FY)Jun 30, 2023(FY)Jun 30, 2022
Operating cash flow (direct method)
Cash income from operating activities -70.19%164.8K285.63%552.9K143.38K
Revenue from customers 4,770.01%164.8K--3.38K----
Other cash income from operating activities ----283.27%549.51K--143.38K
Cash paid -11.51%-5.83M-26.88%-5.23M-4.12M
Payments to suppliers for goods and services -11.51%-5.83M-26.88%-5.23M---4.12M
Direct interest received 70.17%712.68K4,048.96%418.8K--10.09K
Operating cash flow -16.35%-4.95M-7.29%-4.26M---3.97M
Investing cash flow
Cash flow from continuing investing activities -49.51%-3.36K42.81%-2.24K-3.92K
Net PPE purchase and sale -49.51%-3.36K42.81%-2.24K---3.92K
Cash from discontinued investing activities
Investing cash flow -49.51%-3.36K42.81%-2.24K---3.92K
Financing cash flow
Cash flow from continuing financing activities 21.36M
Net common stock issuance ----------21.36M
Cash from discontinued financing activities
Financing cash flow ----------21.36M
Net cash flow
Beginning cash position -15.94%21.4M227.87%25.46M--7.76M
Current changes in cash -16.37%-4.95M-124.48%-4.26M--17.39M
Effect of exchange rate changes -100.42%-843-33.80%198.87K--300.43K
End cash Position -23.16%16.44M-15.94%21.4M--25.46M
Free cash from -16.37%-4.95M-7.24%-4.26M---3.97M
Accounting Standards US-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
% Chg

No Data